Skip to main content
Fig. 5 | Trials

Fig. 5

From: The INVEST project: investigating the use of evidence synthesis in the design and analysis of clinical trials

Fig. 5

Barriers to the use of evidence synthesis (higher scores indicate greatest perceived barriers). Three points were assigned to the greatest barrier, 2 points to the second and 1 to the third. For example, 38 respondents ranked time constraints as the greatest barrier (3 × 38 = 114 points), 21 ranked it second (2 × 21 = 42) and 11 ranked it third (1 × 11 = 11)

Back to article page